Clinical Study on Targeted CD19/BCMA CAR-T Therapy for Autoimmune Diseases

Clinical trial NCT06775912 · RECRUITING

Trial details

NCT number: NCT06775912
Sponsor: Nanjing Bioheng Biotech Co., Ltd.
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

SLE Systemic Sclerosis IIM NMOSD MS MG ANCA Associated Vasculitis (AAV)

Start date: 2025-01-03
Primary completion: 2027-01-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.